Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

OriGene Raises $21.3 Million from China Investors

publication date: Mar 22, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
OriGene Technologies of Maryland has raised $21.3 million in a C round that was led by two China-focused venture funds: Qiming Venture Partners and Kleiner Perkins Caufield Byers China. OriGene is a research tool company that offers an extensive portfolio of full-length human cDNAs in a standard expression vector. Although OriGene is headquartered close to Washington DC, it has three facilities in China. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...